Strecker stent implantation in iliac arteries: patency and predictive factors for long-term success.

Authors:
  • BBB M Beyssen
    B M Beyssen
  • MAM C Auguste
    M C Auguste
  • YBY Le Bras
    Y Le Bras
  • ARA C Raynaud
    A C Raynaud
  • GCG Chatellier
    G Chatellier
  • JGJ C Gaux
    J C Gaux

Abstract
To evaluate Strecker stent implantation in iliac arteries. Sixty-four iliac arteries with Strecker stents were prospectively studied. Stents were placed for dissection (n = 31), total occlusion (n = 28), unsatisfactory results (n = 3) or restenosis (n = 1) after percutaneous transluminal angioplasty, and a calcified atherosclerotic lesion that bulged into the lumen (n = 1). Stent placement was successful in 63 arteries (98%). The overall complication rate was 12% (n = 8). During follow-up, three patients died. The stent was compromised in 18 cases because of hyperplasia (n = 10) or occlusion (n = 8). The primary patency rate was 84% at 1 year and 69% at 2 years; the secondary patency rate was 90% at 1 year and 81% at 2 years. Initial dissection (P = .046), a length of 60 mm or less for the stent region (P = .007), and total covering of the abnormal segment with the stent (P = .03) were significant predictive factors for good, long-term results. Use of the Strecker endoprosthesis appears useful but not ideal. Determination of predictive factors for long-term success may help identify indications for its use.